Septerna Common Stock Stock Today
| SEPN Stock | 26.67 0.32 1.21% |
PerformanceFair
| Odds Of DistressLow
|
Septerna Common is selling at 26.67 as of the 22nd of January 2026; that is 1.21 percent up since the beginning of the trading day. The stock's open price was 26.35. Septerna Common has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 24th of October 2025 and ending today, the 22nd of January 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of October 2024 | Category Healthcare | Classification Health Care |
Septerna Common is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 44.77 M outstanding shares of which 1.43 M shares are at this time shorted by private and institutional investors with about 5.28 trading days to cover. More on Septerna Common Stock
Moving together with Septerna Stock
| 0.68 | BMY | Bristol Myers Squibb | PairCorr |
| 0.82 | JNJ | Johnson Johnson | PairCorr |
| 0.83 | MRK | Merck Company | PairCorr |
| 0.79 | DHT-U | DRI Healthcare Trust | PairCorr |
Moving against Septerna Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Septerna Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsSepterna Common can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Septerna Common's financial leverage. It provides some insight into what part of Septerna Common's total assets is financed by creditors.
| |||||
Septerna Common Stock (SEPN) is traded on NASDAQ Exchange in USA and employs 75 people. Septerna Common is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.18 B. Septerna Common Stock conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 44.77 M outstanding shares of which 1.43 M shares are at this time shorted by private and institutional investors with about 5.28 trading days to cover.
Septerna Common generates negative cash flow from operations
Check Septerna Common Probability Of Bankruptcy
Ownership AllocationThe majority of Septerna Common Stock outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Septerna Common to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Septerna Common Stock. Please pay attention to any change in the institutional holdings of Septerna Common Stock as this could imply that something significant has changed or is about to change at the company.
Check Septerna Ownership Details
Septerna Common Historical Income Statement
Septerna Stock Against Markets
Septerna Common Corporate Management
| Uwe Klein | Senior Sciences | Profile | |
| Richard Hansen | Vice Technology | Profile | |
| MBA CFA | Interim Operations | Profile | |
| MD FACC | Chief Officer | Profile | |
| JD CFA | Chief Officer | Profile | |
| Daniel DPHIL | Senior Discovery | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Septerna Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Septerna Common. If investors know Septerna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Septerna Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.90) | Revenue Per Share | Quarterly Revenue Growth 121.131 | Return On Assets | Return On Equity |
The market value of Septerna Common Stock is measured differently than its book value, which is the value of Septerna that is recorded on the company's balance sheet. Investors also form their own opinion of Septerna Common's value that differs from its market value or its book value, called intrinsic value, which is Septerna Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Septerna Common's market value can be influenced by many factors that don't directly affect Septerna Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Septerna Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Septerna Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Septerna Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.